Molecular imaging lab investigating biomarkers (PET & blood) for neurodegenerative diseases, focusing on early detection & therapeutic intervention in AD.
Melbourne, Australia
Joined August 2022
- Tweets40
- Following305
- Followers146
- Likes18
Rowe Lab retweeted
Don't miss out on the opportunity to join our team! The final day (21st) to apply for this postdoc position is fast approaching.
#AlzheimersDisease #NeuroImaging #BrainScience #AlzheimerResearch #Neuroscience #ClinicalTrials #jobopening #careerdevelopment
🌊🏄♀️ Exciting news! A postdoctoral opportunity is now available in my team in Melbourne! Join us and contribute to cutting-edge research in imaging the aging brain. #postdocopportunity #scienceAustralia 🏖️🐨🦘
jobs.csiro.au/job/Melbourne%…
Rowe Lab retweeted
🌊🏄♀️ Exciting news! A postdoctoral opportunity is now available in my team in Melbourne! Join us and contribute to cutting-edge research in imaging the aging brain. #postdocopportunity #scienceAustralia 🏖️🐨🦘
jobs.csiro.au/job/Melbourne%…
Rowe Lab retweeted
Exciting results!🧠✨Our latest study showcases that plasma P217+tau can distinguish Intermediate or Advanced stage #Alzheimer's, defined based on the 2023 biological PET staging scheme. Dive into the details in our preprint:
medrxiv.org/content/10.1101/…
#AlzheimersResearch
Rowe Lab retweeted
Universal sampling masks for tau imaging (CenTauR) are now available for download on #GAAIN: gaain.org/centaur-project
📢 Australia's @CSIRO researchers and scientists from around the world has developed a universal scale, termed CenTauR, to standardize #tauPET measurements across tracers 👥
CenTauR masks are now available for download on #GAAIN: gaain.org/centaur-project 🧠
Rowe Lab retweeted
Amyloid PET brain imaging is a valuable diagnostic tool for detecting early signs of dementia, Alzheimer's disease and MCI. In this 2 part series, Prof Chris Rowe explains appropriate use of amyloid PET, how to read scans & accurately interpret results buff.ly/3UB2Vjx
Rowe Lab retweeted
Are you looking for a postdoc position in an awesome lab? Come join us! Buckley lab is seeking a postdoc (summer start, negotiable) that will work on a large multi-cohort project investigating resistance and resilience to Alzheimer's disease! bitly.ws/BC3V
#postdocjobs
Rowe Lab retweeted
The Australian Dementia Research Forum will be held at the JW Marriott Gold Coast Resort & Spa, Surfers Paradise, Queensland. ADNeT has negotiated an amazing special rate for our ADRF delegates so get in early and take advantage of this negotiated rate!
buff.ly/3Yv1Z1j
Rowe Lab retweeted
Watch the latest ADNeT webinar : Amyloid PET in clinical practice- Interpretation and clinical significance, presented by ADNeT Director Prof Chris Rowe and Dr Jo Robertson. Find out more and watch it here: buff.ly/3gvV4DT #dementia
Rowe Lab retweeted
ADNeT Director Prof Chris Rowe believes the recent Lecanemab trial results are exciting.“They confirm that treatments that remove amyloid are on the right path and have a real benefit when given to people with established symptoms of Alzheimer’s disease.” buff.ly/3CdRF5g
Rowe Lab retweeted
NEW DATA: Topline data from the confirmatory Phase 3 CLARITY AD trial is now available for our investigational anti-amyloid-beta protofibril antibody. #Alzheimersdisease
Rowe Lab retweeted
We compared 10 p-tau blood assays in our latest paper in @Brain1878! P-tau217 is consistently better than p-tau181, mass-spect (MS) assays are better than best immunoassays, with MS p-tau217 reaching very high accuracy (AUC<0.93)!
doi.org/10.1093/brain/awac33…
Rowe Lab retweeted
NEW: @Colin__Groot showed that A+ persons who are CSF p-tau-/tau PET+ (A+P-T+) accumulate tau pathology in medial temporal and neocortical regions at a faster rate then A+P-T- individuals. Update the biomarker framework to APT(N)?
@biofinder_study @AlzheimerAms @OskarHansson9
The BioFINDER team is proud to present our new paper published in @Brain1878, where we suggest to update the AT(N) system to APT(N) by splitting #tau status derived from #CSF/#plasma (= P [phospho-tau]) and tau #PET (= T).
academic.oup.com/brain/advan…
Rowe Lab retweeted
One of the largest multi-centre & multi-initiative harmonisation study of Amyloid PET images. β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3 - ScienceDirect sciencedirect.com/science/ar…
Rowe Lab retweeted
Landmark brain study stalls due to AFL's lack of support, researcher says. #abc730 @EliasClure abc.net.au/news/2022-08-25/l…